This study will examine the impact of genetic counseling on decisions made regarding reproductive options in women who are known to be at risk for producing an infant with a clinically significant hemoglobinopathy. While the literature shows that genetic counseling is very helpful in providing individuals or families with information to make informed decisions regarding reproductive decisions, professional opinions differ on the optimal time period to initiate genetic counseling. the purpose of this research is twofold: 1) to examine how genetic counseling effects the reproductive decisions of women with a known sickle hemoglobinopathy; 2) to determine the best time (i.e., preconception, prenatal, postnatal) to initiate the counseling process. The women in this study will be identified through three major sources: 1) the Tennessee Department of Health and Environment's newborn screening program, 2) prenatal clinics and 3) community mass screening. Specifically this project will: 1. Examine the differences in responses to reproductive decisions of women who receive counseling and women who do not receive counseling. 2. Examine the differences in reproductive decisions based upon the time counseling information is provided during the pre-conception, prenatal, postnatal periods. 3. Assess the retention of genetic counseling for the five year grant period. 4. Determine what factors impact upon reproductive decision making, i.e., cultural, religious. 5. Increase male participation in the counseling process and case management when a pregnancy or an affected newborn is involved.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Comprehensive Center (P60)
Project #
5P60HL038737-09
Application #
5213678
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
9
Fiscal Year
1996
Total Cost
Indirect Cost
Burch-Sims, G Pamela; Matlock, Valeria R (2005) Hearing loss and auditory function in sickle cell disease. J Commun Disord 38:321-9
Aguinaga, M D; Kutlar, F; Turner, E A et al. (2000) Hb Inkster [alpha85(F6)Asp-->Val] found in a caucasian male with polycythemia. Hemoglobin 24:333-9
Shokrani, M; Terrell, F; Turner, E A et al. (2000) Chromatographic measurements of hemoglobin A2 in blood samples that contain sickle hemoglobin. Ann Clin Lab Sci 30:191-4
Popp, R A; Shinpock, S G; Qopp, D M et al. (1998) Erythropoietin level and effect of rHuEPO in beta-thalassemic mice. Ann N Y Acad Sci 850:455-8
Iyamu, E W; Roa, P D; Kopsombut, P et al. (1998) New isocratic high-performance liquid chromatographic procedure to assay the anti-sickling compound hydroxyurea in plasma with ultraviolet detection. J Chromatogr B Biomed Sci Appl 709:119-26
Roa, D; Kopsombut, P; Aguinaga, M P et al. (1997) Hydroxyurea-induced denaturation of normal and sickle cell hemoglobins in vitro. J Clin Lab Anal 11:208-13
Roa, D; Turner, E A; Aguinaga, M D (1995) Reference ranges for hemoglobin variants by HPLC in African Americans. Ann Clin Lab Sci 25:228-35
Robbins, V; Aguinaga, M P; Valenzuela, M S (1995) Efficient isolation of whole genomic DNA from cell cultures and blood samples. Biotechniques 18:414-6, 418
Roa, P D; Turner, E A; Aguinaga, M del P (1993) Hemoglobin variant detection from dried blood specimens by high performance liquid chromatography. Ann Clin Lab Sci 23:433-8
Chakrabarti, A; Sitaric, S; Ohi, S (1992) A procedure for large-scale plasmid isolation without using ultracentrifugation. Biotechnol Appl Biochem 16:211-5

Showing the most recent 10 out of 17 publications